1130 Bull. Chem. Soc. Jpn., 78, No. 6 (2005)
Concave-Shaped Conformation in Crystal
7.29–7.27 (m, 4H), 7.14–7.13 (m, 2H), 5.60 (t, J ¼ 6:9 Hz, 2H),
5.04 (m7, J ¼ 6:9 Hz, 1H), 4.91 (s, 4H), 1.51 (d, J ¼ 6:7 Hz,
6H). 13C NMR (CDCl3, 125 MHz) ꢄ 169.4 (s), 159.2 (s), 141.5
(d), 140.1 (d), 135.2 (s), 129.0 (d), 128.9 (d), 128.4 (d), 105.2
(d), 52.5 (t), 49.4 (d), 20.5 (q). MS (EI) m=z 481 [Mþ]. Anal.
Calcd for C29H27N3O4: C, 72.33; H, 5.65; N, 8.73%. Found: C,
72.01; H, 5.63; N, 8.66%.
C, 66.83; H, 8.07; N, 11.13%. Found: C, 66.51; H, 5.07; N,
11.07%.
Photocycloaddition in Solid-State. Ground crystals of 1a
(0.020 g, 0.042 mmol) were placed between two glass plates.
The sandwiched sample was placed in a transparent polyethylene
bag. UV irradiation was carried out externally on this sample with
a 400 W high-pressure mercury lamp through a Pyrex filter for 6 h
at ca. 23 ꢁC in a water bath. Without purification, 2a was obtained
as a pure product in quantitative yield. The cycloadduct 2a was
recrystallized from hexane/ethyl acetate to give colorless crystals.
In a similar way as for 2a, other [4 þ 4] photocycloadducts 2b–2h
were obtained. The irradiation time and their yields are given in
Table 2.
1,10-Dibenzyl-3,3ꢁ0-(N-butyliminodicarbonyl)di-2-pyridone
1
(1b): mp 167–169 C (yellow crystals). H NMR (CDCl3, 500
MHz) ꢄ 7.49 (dd, J ¼ 7:1, 2.2 Hz, 2H), 7.37–7.26 (m, 10H),
7.16 (dd, J ¼ 6:9, 2.1 Hz, 2H), 5.62 (t, J ¼ 6:7 Hz, 2H), 4.92
(s, 4H), 3.98 (br, 2H), 1.76 (m, J ¼ 7:6 Hz, 2H), 1.42 (m6, J ¼
7:3 Hz, 2H), 0.94 (t, J ¼ 7:3 Hz, 3H). 13C NMR (CDCl3, 125
MHz) ꢄ 169.4 (s), 159.3 (s), 141.7 (d), 140.1 (d), 135.3 (s),
129.0 (d), 128.9 (d), 128.4 (d), 128.3 (s), 105.3 (d), 52.5 (t),
45.3 (t), 30.6 (t), 20.3 (t), 13.9 (q). MS (EI) m=z 495 [Mþ]. Anal.
Calcd for C30H29N3O4: C, 72.71; H, 5.90; N, 8.48%. Found: C,
72.61; H, 5.87; N, 8.39%.
1,10-Dibenzyl-3,30-(N-benzyliminodicarbonyl)di-2-pyridone
(1c): mp. 169–171 ꢁC (yellow crystals). IR (KBr) 3067 (m), 3031
(m), 1656 (s), 1582 (s), 1549 (s), 1244 (s) cmꢃ1. UV–vis (CH3CN)
ꢃmax ("), 257 (3200), 285 (2500), 343 (10000) nm. 1H NMR
(CDCl3, 400 MHz) ꢄ 7.54 (td, J ¼ 7:1, 2.1 Hz, 4H), 7.35–7.17
(m, 13H), 7.14 (dd, J ¼ 5:9, 2.2 Hz, 2H), 5.66 (t, J ¼ 6:9 Hz,
2H), 5.20 (s, 2H), 4.91 (s, 4H). 13C NMR (CDCl3, 125 MHz) ꢄ
169.3 (s), 159.2 (s), 142.1 (d), 140.3 (d), 137.5 (s), 135.3 (s),
128.8 (d), 128.3 (d), 128.2 (d), 127.9 (d), 127.7 (s), 126.8 (d),
105.2 (d), 52.4 (t), 48.6 (t). MS (EI) m=z 529 [Mþ]. Anal. Calcd
for C33H27N3O4: C, 74.84; H, 5.14; N, 7.93%. Found: C, 74.84;
H, 5.10; N, 7.87%.
1,10-Dimethyl-3,30-(N-isopropyliminodicarbonyl)di-2-pyri-
done (1d): mp. 220–222 ꢁC (yellow crystals). IR (KBr) 2976
(w), 1657 (s), 1590 (s), 1549 (s), 1268 (s) cmꢃ1. UV–vis (CH3CN)
ꢃmax ("), 252 (2700), 282 (2700), 340 (10000), 374 (4700) nm.
1H NMR (CDCl3, 500 MHz) ꢄ 7.75 (dd, J ¼ 7:3, 2.1 Hz, 2H),
7.24 (dd, J ¼ 6:6, 2.3 Hz, 2H), 6.04 (t, J ¼ 6:9 Hz, 2H), 4.98
(m7, J ¼ 6:9 Hz, 1H), 3.41 (s, 6H), 1.52 (d, J ¼ 6:7 Hz, 6H).
13C NMR (CDCl3, 125 MHz) ꢄ 169.3 (s), 159.8 (s), 141.5 (d),
141.3 (d), 128.6 (s), 104.9 (d), 49.5 (d), 37.9 (q), 20.3 (q). MS
(EI) m=z 329 [Mþ]. Anal. Calcd for C17H19N3O4: C, 62.00; H,
5.81; N, 12.76%. Found: C, 61.73; H, 5.80; N, 12.71%.
3,11-Dibenzyl-7-isopropyl-3,7,11-triazatetracyclo[7.2.2.2.2,5
-
05,9]pentadeca-12,14-diene-4,6,8,10-tetrone (2a): mp 158–160
ꢁC. IR (KBr) 2979 (w), 1784 (m), 1714 (s), 1676 (s), 1454 (m),
1370 (s), 1264 (s) cmꢃ1. UV–vis (CH3CN) ꢃmax ("), 258 (160)
nm. 1H NMR (CDCl3, 500 MHz) ꢄ 7.33–7.26 (m, 6H), 7.14–
7.12 (m, 4H), 6.36 (d, J ¼ 7:7 Hz, 2H), 6.26 (ddd, J ¼ 8:1, 4.7,
2.2 Hz, 2H), 5.06 (d, J ¼ 15 Hz, 2H), 4.56 (m7, J ¼ 7:0 Hz,
1H), 4.09 (m, 2H), 3.67 (d, J ¼ 15 Hz, 2H), 1.53 (d, J ¼ 7:0
Hz, 3H), 1.50 (d, J ¼ 7:0 Hz, 3H). 13C NMR (CDCl3, 125
MHz) ꢄ 172.6 (s), 168.2 (s), 135.1 (s), 133.6 (d), 132.1 (d),
128.9 (d), 128.2 (d), 61.9 (s), 57.9 (d), 50.5 (t), 45.4 (d), 19.4
(q), 19.0 (q). MS (EI) m=z 481 [Mþ]. Anal. Calcd for
C29H27N3O4: C, 72.33; H, 5.65; N, 8.73%. Found: C, 72.23; H,
5.63; N, 8.64%.
3,11-Dibenzyl-7-butyl-3,7,11-triazatetracyclo[7.2.2.2.2,505,9]-
pentadeca-12,14-diene-4,6,8,10-tetrone (2b): 1H NMR (CDCl3,
500 MHz) ꢄ 7.34–7.13 (m, 10H), 6.39 (d, J ¼ 8:2 Hz, 2H), 6.28
(m, 2H), 5.10 (d, J ¼ 15 Hz, 2H), 4.09 (m, 2H), 3.75 (dt,
J ¼ 13, 7.0 Hz, 1H), 3.69–3.65 (m, 3H), 1.76–1.66 (m, 2H),
1.42 (sext, J ¼ 7:3 Hz, 2H), 0.97 (t, J ¼ 7:3 Hz, 3H). 13C NMR
(CDCl3, 125 MHz) ꢄ 172.7 (s), 168.2 (s), 135.1 (s), 133.7 (d),
132.1 (d), 129.0 (d), 128.2 (d), 128.2 (d), 62.4 (s), 57.8 (d), 50.6
(t), 39.9 (t), 29.6 (t), 19.8 (t), 13.7 (q). MS (EI) m=z 495 [Mþ].
Anal. Calcd for C30H29N3O4: C, 72.71; H, 5.90; N, 8.48%. Found:
C, 72.42; H, 5.87; N, 8.34%.
3,7,11-Tribenzyl-3,7,11-triazatetracyclo[7.2.2.2.2,505,9]penta-
deca-12,14-diene-4,6,8,10-tetrone (2c): mp. 160–162 ꢁC. IR
(KBr) 3061 (w), 1787 (m), 1717 (s), 1672 (s), 1398 (m), 1245
(m) cmꢃ1. UV–vis (CH3CN) ꢃmax ("), 259 (970) nm. 1H NMR
(CDCl3, 500 MHz) ꢄ 7.44 (d, J ¼ 7:3 Hz, 2H), 7.37–7.26 (m,
9H), 7.12 (dd, J ¼ 7:7, 1.7 Hz, 4H), 6.37 (d, J ¼ 8:0 Hz, 2H),
6.28 (ddd, J ¼ 8:1, 4.7, 2.1 Hz, 2H), 5.10 (d, J ¼ 15 Hz, 2H),
4.94 (d, J ¼ 15 Hz, 1H), 4.82 (d, J ¼ 15 Hz, 1H), 4.08 (m,
2H), 3.65 (d, J ¼ 15 Hz, 2H). 13C NMR (CDCl3, 125 MHz) ꢄ
172.4 (s), 168.0 (s), 135.0 (s), 134.7 (s), 133.7 (d), 131.9 (d),
129.0 (d), 128.8 (d), 128.2 (d), 128.1 (d), 127.9 (d), 62.5 (s),
57.7 (d), 50.5 (t), 43.5 (t). MS (EI) m=z 530 [MHþ]. Anal. Calcd
for C33H27N3O4: C, 74.84; H, 5.14; N, 7.93%. Found: C, 74.76; H,
5.09; N, 7.88%.
1,10-Dimethyl-3,30-(N-propyliminodicarbonyl)di-2-pyridone
(1e): mp. 190–191 ꢁC (yellow crystals). IR (KBr) 2960 (w), 1657
.
(s), 1585 (m), 1546 (s), 1082 (m), 768 (m) cmꢃ1 1H NMR
(CDCl3, 500 MHz) ꢄ 7.79 (dd, J ¼ 7:0, 2.2 Hz, 2H), 7.24 (dd,
J ¼ 6:6, 2.1 Hz, 2H), 6.06 (t, J ¼ 7:1 Hz, 2H), 3.96 (br, 2H),
3.41 (s, 6H), 1.78 (m6, J ¼ 7:7 Hz, 2H), 0.99 (t, J ¼ 7:3 Hz,
3H). 13C NMR (CDCl3, 125 MHz) ꢄ 169.3 (s), 159.9 (s), 141.9
(d), 141.4 (d), 128.0 (s), 105.0 (d), 46.9 (t), 38.0 (q), 21.9 (t),
11.5 (q). MS (EI) m=z 329 [Mþ]. Anal. Calcd for C17H19N3O4:
C, 62.00; H, 5.81; N, 12.76%. Found: C, 61.94; H, 5.77; N,
12.73%.
1,10-Dimethyl-3,30-(N-benzyliminodicarbonyl)di-2-pyridone
(1f): mp. 206–208 ꢁC (yellow crystals). IR (KBr) 3063 (w), 1693
(m), 1656 (s), 1593 (s), 1549 (s), 1295 (m) cmꢃ1. UV–vis
(CH3CN) ꢃmax ("), 252 (4500), 282 (4200), 341 (10000), 372
(6000) nm. 1H NMR (CDCl3, 500 MHz) ꢄ 7.77 (dd, J ¼ 7:1,
2.2 Hz, 2H), 7.54 (d, J ¼ 7:4 Hz, 2H), 7.39–7.18 (m, 5H), 6.02
(t, J ¼ 6:9 Hz, 2H), 5.19 (s, 2H), 3.36 (s, 6H). 13C NMR (CDCl3,
125 MHz) ꢄ 169.1 (s), 159.7 (s), 142.2 (d), 141.8 (d), 137.5 (s),
128.2 (d), 127.8 (d), 127.3 (s), 126.7 (d), 104.9 (d), 48.4 (t),
37.9 (q). MS (EI) m=z 377 [Mþ]. Anal. Calcd for C21H19N3O4:
3,11-Dimethyl-7-isopropyl-3,7,11-triazatetracyclo[7.2.2.2.ꢁ2,5
-
05,9]pentadeca-12,14-diene-4,6,8,10-tetrone (2d): mp. 170 C.
IR (KBr) 2988 (w), 1784 (w), 1719 (s), 1673 (s), 1458 (w),
1399 (m), 1265 (m) cmꢃ1. UV–vis (CH3CN) ꢃmax ("), 258
(540) nm. 1H NMR (CDCl3, 500 MHz) ꢄ 6.62–6.56 (m, 2H),
6.36 (dd, J ¼ 8:7, 0.8 Hz, 2H), 4.53 (m7, J ¼ 7:0 Hz, 1H), 4.23
(m, 2H), 2.89 (s, 6H), 1.50 (d, J ¼ 7:0 Hz, 3H), 1.48 (d, J ¼
7:1 Hz, 3H). 13C NMR (CDCl3, 125 MHz) ꢄ 172.6 (s), 168.0
(s), 132.8 (d), 132.0 (d), 62.0 (s), 61.3 (d), 45.2 (d), 35.3 (q),
19.2 (q), 18.9 (q). MS (EI) m=z 329 [Mþ]. Anal. Calcd for